{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:57:17Z","timestamp":1783573037721,"version":"3.55.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,5]],"date-time":"2018-07-05T00:00:00Z","timestamp":1530748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s40261-018-0673-x","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T13:02:07Z","timestamp":1551790927000},"page":"829-835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7483-1980","authenticated-orcid":false,"given":"Seuk Keun","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2329-8834","authenticated-orcid":false,"given":"Chan Wha","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3200-9849","authenticated-orcid":false,"given":"Jong-Tak","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0220-9401","authenticated-orcid":false,"given":"Young","family":"Seomun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4395-9938","authenticated-orcid":false,"given":"Min Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-1108","authenticated-orcid":false,"given":"Choon Ok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,5]]},"reference":[{"issue":"Suppl 5","key":"673_CR1","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/cc3779","volume":"9","author":"DS Kauvar","year":"2005","unstructured":"Kauvar DS, Wade CE. The epidemiology and modern management of traumatic hemorrhage: US and international perspectives. Crit Care. 2005;9(Suppl 5):S1\u20139.","journal-title":"Crit Care"},{"key":"673_CR2","doi-asserted-by":"crossref","unstructured":"Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, Fernandez-Mondejar E, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.","DOI":"10.1186\/s13054-016-1265-x"},{"issue":"5","key":"673_CR3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1365-2141.2011.08885.x","volume":"155","author":"R Davenport","year":"2011","unstructured":"Davenport R, Khan S. Management of major trauma haemorrhage: treatment priorities and controversies. Br J Haematol. 2011;155(5):537\u201348.","journal-title":"Br J Haematol"},{"key":"673_CR4","doi-asserted-by":"crossref","unstructured":"Douketis JD, Berger PB, Dunn AS, Jaffer AK, Spyropoulos AC, Becker RC, et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(6 Suppl):299S\u2013339S.","DOI":"10.1378\/chest.08-0675"},{"issue":"2","key":"673_CR5","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.transci.2012.06.001","volume":"47","author":"J Seghatchian","year":"2012","unstructured":"Seghatchian J, Samama MM. Massive transfusion: an overview of the main characteristics and potential risks associated with substances used for correction of a coagulopathy. Transf Apher Sci. 2012;47(2):235\u201343.","journal-title":"Transf Apher Sci."},{"issue":"1","key":"673_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1378\/chest.09-0252","volume":"137","author":"KC Sihler","year":"2010","unstructured":"Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137(1):209\u201320.","journal-title":"Chest"},{"key":"673_CR7","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/asheducation.V2012.1.517.3798536","volume":"2012","author":"S Schulman","year":"2012","unstructured":"Schulman S. Pharmacologic tools to reduce bleeding in surgery. Hematol Am Soc Hematol Educ Program. 2012;2012:517\u201321.","journal-title":"Hematol Am Soc Hematol Educ Program."},{"issue":"12","key":"673_CR8","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1021\/acsbiomaterials.5b00356","volume":"1","author":"VA Kumar","year":"2015","unstructured":"Kumar VA, Wickremasinghe NC, Shi S, Hartgerink JD. Nanofibrous snake venom hemostat. ACS Biomater Sci Eng. 2015;1(12):1300\u20135.","journal-title":"ACS Biomater Sci Eng."},{"key":"673_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.actbio.2016.10.024","volume":"48","author":"GM Seon","year":"2017","unstructured":"Seon GM, Lee MH, Kwon BJ, Kim MS, Koo MA, Kim D, et al. Functional improvement of hemostatic dressing by addition of recombinant batroxobin. Acta Biomater. 2017;48:175\u201385.","journal-title":"Acta Biomater"},{"issue":"4","key":"673_CR10","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00402-015-2183-0","volume":"135","author":"H Hu","year":"2015","unstructured":"Hu H, Chen L, Frary CE, Chang C, Hui H, Zhang H, et al. The beneficial effect of Batroxobin on blood loss reduction in spinal fusion surgery: a prospective, randomized, double-blind, placebo-controlled study. Arch Orthop Trauma Surg. 2015;135(4):491\u20137.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"673_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0038-1648004","volume":"36","author":"DL Aronson","year":"1976","unstructured":"Aronson DL. Comparison of the actions of thrombin and the thrombin-like venom enzymes ancrod and batroxobin. Thromb Haemost. 1976;36(1):9\u201313.","journal-title":"Thromb Haemost"},{"issue":"1\u20133","key":"673_CR12","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.febslet.2004.06.060","volume":"571","author":"W You","year":"2004","unstructured":"You W, Choi W, Koh Y, Shin H, Jang Y, Chung K. Functional characterization of recombinant batroxobin, a snake venom thrombin-like enzyme, expressed from Pichia pastoris. FEBS Lett. 2004;571(1\u20133):67\u201373.","journal-title":"FEBS Lett"},{"issue":"3","key":"673_CR13","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1432-1033.1995.tb20326.x","volume":"228","author":"G Lochnit","year":"1995","unstructured":"Lochnit G, Geyer R. Carbohydrate structure analysis of batroxobin, a thrombin-like serine protease from Bothrops moojeni venom. Eur J Biochem. 1995;228(3):805\u201316.","journal-title":"Eur J Biochem"},{"issue":"6","key":"673_CR14","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1365-2516.2009.02080.x","volume":"15","author":"G Jayandharan","year":"2009","unstructured":"Jayandharan G, Nair S, Poonnoose P, Thomas R, John J, Keshav S, et al. Polymorphism in factor VII gene modifies phenotype of severe haemophilia. Haemophilia. 2009;15(6):1228\u201336.","journal-title":"Haemophilia"},{"key":"673_CR15","doi-asserted-by":"crossref","unstructured":"Key NS, Makris M, Lillicrap D. Practical hemostasis and thrombosis. 3rd ed. Chichester, West Sussex: Wiley; 2017.","DOI":"10.1002\/9781118344729"},{"key":"673_CR16","unstructured":"Hughes-Jones NC, Wickramasinghe SN, Hatton C. Lecture notes haematology. Chichester: Wiley; 2008."},{"issue":"5","key":"673_CR17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1213\/ane.0b013e31819bcc9c","volume":"108","author":"KA Tanaka","year":"2009","unstructured":"Tanaka KA, Key NS, Levy JH. Blood coagulation: hemostasis and thrombin regulation. Anesth Analg. 2009;108(5):1433\u201346.","journal-title":"Anesth Analg"},{"issue":"1","key":"673_CR18","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00402-011-1390-6","volume":"132","author":"C Xu","year":"2012","unstructured":"Xu C, Wu A, Yue Y. Which is more effective in adolescent idiopathic scoliosis surgery: batroxobin, tranexamic acid or a combination? Arch Orthop Trauma Surg. 2012;132(1):25\u201331.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"1","key":"673_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18549\/PharmPract.2016.01.708","volume":"14","author":"KA Liu","year":"2016","unstructured":"Liu KA, Dipietro Mager NA. Women\u2019s involvement in clinical trials: historical perspective and future implications. Pharm Pract (Granada). 2016;14(1):1\u20139.","journal-title":"Pharm Pract (Granada)."}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40261-018-0673-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-018-0673-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T22:15:06Z","timestamp":1574201706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40261-018-0673-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1007\/s40261-018-0673-x","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]},"assertion":[{"value":"5 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was funded by NC bit Inc., Seongnam, Korea.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jong-Tak Kim and Young Seomun are full-time employees of NC bit Inc, but they did not play a major role in the study design or data analysis. The other authors report no conflicts of interest related to this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional Review Board (IRB) of Severance Hospital, Yonsei University College of Medicine (Seoul, Korea) approved the study protocol before the study was conducted (IRB number: 4-2014-0661). All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}